The Facilities for Illness Management and Prevention (CDC) urged labs this week to inventory clinics with kits that may take a look at for each the coronavirus and the flu because the “influenza season” attracts close to.
The CDC mentioned Wednesday it would withdrawal its request for the “Emergency Use Authorization” of real-time diagnostic testing kits, which had been used beginning in February 2020 to detect indicators of the coronavirus, by the tip of the 12 months.
FLU SHOT PROTECTS AGAINST SOME SEVERE COVID-19 EFFECTS, STUDY CLAIMS
“CDC is offering this advance discover for medical laboratories to have enough time to pick out and implement one of many many FDA-authorized options,” the company mentioned.
The U.S. has reported greater than 34.4 million instances of the coronavirus because the pandemic started in 2020 and greater than 610,000 deaths.
However whereas instances of COVID-19 soared nationwide, hospitalizations and deaths attributable to influenza dropped.
In response to knowledge launched by the CDC earlier this month, influenza mortality charges had been considerably decrease all through 2020 than earlier years.
CHICAGO, BOSTON, ATLANTA JOIN GROWING LIST OF CITIES REQUIRING STUDENTS WEAR MASKS
There have been 646 deaths referring to the flu amongst adults reported in 2020, whereas in 2019 the CDC estimated that between 24,000 and 62,000 folks died from influenza-related diseases.
The CDC urged laboratories to “save each time and assets” by introducing kits that may decide and distinguish a constructive take a look at for the coronavirus and flu.
CLICK HERE TO GET THE FOX NEWS APP
“CDC encourages laboratories to think about adoption of a multiplexed methodology that may facilitate detection and differentiation of SARS-CoV-2 and influenza viruses,” the company mentioned Wednesday.
Laboratories may have till the shut of 2021 earlier than the CDC formally withdrawals its Emergency Use Authorization of the Actual-Time RT-PCR Diagnostic Panel.